Medtronic to Acquire Contego Medical for $380 Million
Medtronic has agreed to acquire privately held Contego Medical for $380 million, adding carotid artery and peripheral thrombectomy technologies to its portfolio. The deal includes Contego’s recently FDA-approved Neuroguard IEP direct system, which combines transcarotid artery revascularization with embolic protection and flow reversal.
November 16, 2026, 04:26 PM 1,566 0
Medtronic said Monday that the purchase includes potential post-acquisition payments. Contego, a medical-technology company based in Galway, Ireland, expects the transaction to close in the third quarter of Medtronic’s 2027 fiscal year, which began April 25.
The companies had an existing U.S. commercial arrangement: Medtronic announced an exclusive U.S. distribution agreement with Contego in January 2025.
Comments (0)
No comments yet. Be the first!